Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Patients with chronic obstructive pulmonary disease (COPD) present with a variety of symptoms and pathological consequences. Although primarily viewed as a respiratory disease, COPD has both pulmonary and extrapulmonary effects, which have an impact on many aspects of physical, emotional, and mental well-being. Traditional assessment of COPD relies heavily on measuring lung function, specifically forced expiratory volume in 1 second (FEV(1)). However, the evidence suggests that FEV(1) is a relatively poor correlate of symptoms such as breathlessness and the impact of COPD on daily life. Furthermore, many consequences of the disease, including anxiety and depression and the ability to perform daily activities, can only be described and reported reliably by the patient. Thus, in order to provide a comprehensive view of the effects of interventions in clinical trials, it is essential that spirometry is accompanied by assessments using patient-reported outcome (PRO) instruments. We provide an overview of patient-reported outcome concepts in COPD, such as breathlessness, physical functioning, and health status, and evaluate the tools used for measuring these concepts. Particular attention is given to the newly developed instruments emerging in response to recent regulatory guidelines for the development and use of PROs in clinical trials. We conclude that although data from the development and validation of these new PRO instruments are emerging, to build the body of evidence that supports the use of a new instrument takes many years. Furthermore, new instruments do not necessarily have better discriminative or evaluative properties than older instruments. The development of new PRO tools, however, is crucial, not only to ensure that key COPD concepts are being reliably measured but also that the relevant treatment effects are being captured in clinical trials. In turn, this will help us to understand better the patient's experience of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Jones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1321 · Cited by 3,035 · cited 2×
“3,61 It has been used in many trials and has demonstrated responsiveness to pharmacological therapy within 6–8 weeks, 66 and was able to identify treatment effects maintained over 3–4 years.”
Self-citationA questionnaire for the assessment of leisure time physical activities
Taylor, H. L., Jacobs, D. R., Schucker, B., Knudsen, J., Leon, A. S., & Debacker, G. (1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90058-9 · Cited by 1,848
A measure of quality of life for clinical trials in chronic lung disease
Guyatt, G. H., Berman, L. B., Townsend, M., Pugsley, S. O., & Chambers, L. W. (1987) · Thorax · doi:10.1136/thx.42.10.773 · Cited by 1,721 · cited 1×
“Originally developed in 1987 based on the responses of 100 patients with COPD, the questionnaire includes 20 items across four domains, namely dyspnea, fatigue, emotional function, and mastery.(72,73) Patients rate their experiences with COPD on a seven-point Likert-type scale, ranging from 1 (maximum impairment) to 7…”
Characteristics of physical activities in daily life in chronic obstructive pulmonary disease
Pitta, F., Troosters, T., Spruit, M. A., Probst, V. S., Decramer, M., & Gosselink, R. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-855oc · Cited by 1,256 · cited 1×
“Physical functioning COPD causes considerable impairment of patients’ physical functioning, leading to limitations in their ability to perform daily activities, such as personal care, physical exercise, and attendance at social events.(42,43) The most common complaint of patients with COPD is that their condition prev…”
Characterisation of COPD heterogeneity in the ECLIPSE cohort
the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators, Agusti, A., Calverley, P. M., Celli, B., Coxson, H. O., Edwards, L. D., Lomas, D. A., MacNee, W., Miller, B. E., Rennard, S., et al. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-122 · Cited by 1,157 · cited 1×
“The SGRQ has been used in ECLIPSE, a large 3-year biomarker study, 70 and has been shown to be responsive to therapy.”
Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12
Yorke, J., Moosavi, S. H., Shuldham, C., & Jones, P. W. (2010) · Thorax · doi:10.1136/thx.2009.118521 · Cited by 369 · cited 1×
“breathlessness and has good measurement properties when used in its target diseases and asthma.(40,41) The minimally important difference is yet to be established.”
Self-citationMeguro, M., Barley, E. A., Spencer, S., & Jones, P. W. (2007) · Chest · doi:10.1378/chest.06-0702 · Cited by 350 · cited 1×
“Introduced in 2007, the COPD version of the SGRQ (SGRQ-C) is a revised and slightly shorter version specifically for COPD that produces scores directly analogous to those from the original.(69) It was revised using Rasch analysis of responses from COPD patients and validated using data from the original validation stu…”
Self-citationReilly, M. C., Gooch, K. L., Wong, R. L., Kupper, H., & van der Heijde, D. (2010) · Rheumatology · doi:10.1093/rheumatology/kep457 · Cited by 242
Reilly, M. C., Bracco, A., Ricci, J. ‐., Santoro, J., & Stevens, T. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02091.x · Cited by 196
Cited by
Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission
Stolz, D., Mkorombindo, T., Schumann, D. M., Agusti, A., Ash, S. Y., Bafadhel, M., Bai, C., Chalmers, J. D., Criner, G. J., Dharmage, S. C., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01273-9 · Cited by 681
Müllerová, H., Lu, C., Li, H., & Tabberer, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085540 · Cited by 139
Metadata
- Authors
- Jones, P., Miravitlles, M., van der Molen, T., & Kulich, K.
- Venue
- International Journal of Chronic Obstructive Pulmonary Disease
- Publisher
- Informa UK Limited
- Published
- 2012-10
- Volume
- 7
- Pages
- 697
- ISSN
- 1176-9106 (ISSN-L)
- 1178-2005
- OpenAlex
- W2147204689
- Cited by
- 168
- References
- 11
- FWCI
- 12.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.